BACKGROUND: Young women with acute coronary syndrome (ACS) may represent a high risk group, but little is known about specific age and sex differences in clinical characteristics, treatment, outcomes, and trends over time. METHODS: Data from 3237 men and women admitted with an ACS event from 1999 to 2006 were analyzed. Patients were grouped by sex and age less than 55 years. Demographics, presentation, treatment, and outcomes at 6 months were analyzed. Primary outcomes included mortality, recurrent myocardial infarction, rehospitalization, and stroke at 6 months. Secondary analyses assessed risk factors, management, and trends over time. RESULTS: Women under 55 years represented 8% of the entire cohort, and 26% of patients under age 55 years. Compared to older women, young women were more likely to be smokers (51 vs. 14%, p < 0.001) and obese (44 vs. 34%, p = 0.006). Young women had more diabetes and hypertension than young men. Mortality was lowest among young women and did not change over time. Young women received less treatment with aspirin, beta blockers, lipid-lowering agents, and ACE inhibitors, and underwent less coronary angiography and stenting than young men (44 vs. 59%, p < 0.001). Rehospitalization was higher among young women than young men (37 vs. 27%, p < 0.001), with no change over time. CONCLUSIONS: Modifiable risk factors such as smoking, obesity, diabetes, and hypertension should be addressed in young women. Following ACS, young women received fewer evidence-based medications, were treated less invasively, and had higher readmission rates within 6 months compared to young men.
BACKGROUND: Young women with acute coronary syndrome (ACS) may represent a high risk group, but little is known about specific age and sex differences in clinical characteristics, treatment, outcomes, and trends over time. METHODS: Data from 3237 men and women admitted with an ACS event from 1999 to 2006 were analyzed. Patients were grouped by sex and age less than 55 years. Demographics, presentation, treatment, and outcomes at 6 months were analyzed. Primary outcomes included mortality, recurrent myocardial infarction, rehospitalization, and stroke at 6 months. Secondary analyses assessed risk factors, management, and trends over time. RESULTS:Women under 55 years represented 8% of the entire cohort, and 26% of patients under age 55 years. Compared to older women, young women were more likely to be smokers (51 vs. 14%, p < 0.001) and obese (44 vs. 34%, p = 0.006). Young women had more diabetes and hypertension than young men. Mortality was lowest among young women and did not change over time. Young women received less treatment with aspirin, beta blockers, lipid-lowering agents, and ACE inhibitors, and underwent less coronary angiography and stenting than young men (44 vs. 59%, p < 0.001). Rehospitalization was higher among young women than young men (37 vs. 27%, p < 0.001), with no change over time. CONCLUSIONS: Modifiable risk factors such as smoking, obesity, diabetes, and hypertension should be addressed in young women. Following ACS, young women received fewer evidence-based medications, were treated less invasively, and had higher readmission rates within 6 months compared to young men.
Authors: Farhan J Khawaja; Nilay D Shah; Ryan J Lennon; Joshua P Slusser; Aziz A Alkatib; Charanjit S Rihal; Bernard J Gersh; Victor M Montori; David R Holmes; Malcolm R Bell; Jeptha P Curtis; Harlan M Krumholz; Henry H Ting Journal: Arch Intern Med Date: 2011-11-28
Authors: Tony Shang-Chuan Chen; Alexander Incani; Tom C Butler; Karl Poon; Jinlin Fu; Michael Savage; Margaret Dahl; Donna E Callow; Daniel Colburn; Chris Hammett; Darren L Walters Journal: Heart Lung Circ Date: 2013-06-21 Impact factor: 2.975
Authors: Lori Mosca; Emelia J Benjamin; Kathy Berra; Judy L Bezanson; Rowena J Dolor; Donald M Lloyd-Jones; L Kristin Newby; Ileana L Piña; Véronique L Roger; Leslee J Shaw; Dong Zhao; Theresa M Beckie; Cheryl Bushnell; Jeanine D'Armiento; Penny M Kris-Etherton; Jing Fang; Theodore G Ganiats; Antoinette S Gomes; Clarisa R Gracia; Constance K Haan; Elizabeth A Jackson; Debra R Judelson; Ellie Kelepouris; Carl J Lavie; Anne Moore; Nancy A Nussmeier; Elizabeth Ofili; Suzanne Oparil; Pamela Ouyang; Vivian W Pinn; Katherine Sherif; Sidney C Smith; George Sopko; Nisha Chandra-Strobos; Elaine M Urbina; Viola Vaccarino; Nanette K Wenger Journal: Circulation Date: 2011-02-14 Impact factor: 29.690
Authors: Hoa L Nguyen; Joel M Gore; Jane S Saczynski; Jorge Yarzebski; George Reed; Frederick A Spencer; Robert J Goldberg Journal: Circ Cardiovasc Qual Outcomes Date: 2010-10-19
Authors: Karl Fengler; Georg Fuernau; Steffen Desch; Ingo Eitel; Franz-Josef Neumann; Hans-Georg Olbrich; Antoinette de Waha; Suzanne de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Rainer Hambrecht; Jörg Fuhrmann; Michael Böhm; Janine Poess; Ruth Strasser; Steffen Schneider; Gerhard Schuler; Karl Werdan; Uwe Zeymer; Holger Thiele Journal: Clin Res Cardiol Date: 2014-10-07 Impact factor: 5.460
Authors: C Eick; M Duckheim; P Groga-Bada; N Klumpp; S Mannes; C S Zuern; M Gawaz; K D Rizas; Axel Bauer Journal: Clin Res Cardiol Date: 2017-03-22 Impact factor: 5.460
Authors: Petra Hillinger; Raphael Twerenbold; Karin Wildi; Maria Rubini Gimenez; Cedric Jaeger; Jasper Boeddinghaus; Thomas Nestelberger; Karin Grimm; Tobias Reichlin; Fabio Stallone; Christian Puelacher; Zaid Sabti; Nikola Kozhuharov; Ursina Honegger; Paola Ballarino; Oscar Miro; Kris Denhaerynck; Temizel Ekrem; Claudia Kohler; Roland Bingisser; Stefan Osswald; Christian Mueller Journal: Clin Res Cardiol Date: 2016-07-12 Impact factor: 5.460
Authors: Ersilia M DeFilippis; Bradley L Collins; Avinainder Singh; David W Biery; Amber Fatima; Arman Qamar; Adam N Berman; Ankur Gupta; Mary Cawley; Malissa J Wood; Josh Klein; Jon Hainer; Martha Gulati; Viviany R Taqueti; Marcelo F Di Carli; Khurram Nasir; Deepak L Bhatt; Ron Blankstein Journal: Eur Heart J Date: 2020-11-07 Impact factor: 29.983